CMHC 2014 Symposium: Obesity Management

Type 2 diabetes and obesity are very much intertwined and treatment of each disease affects the other. This activity will explore obesity's biologic causes, clinical consequences, and the expanding armamentarium of weight control methods, especially in those special populations affected by prediabetes and diabetes. Clinicians will refine their ability to evaluate comorbidities and select obesity therapies that are safe, effective, and individualized for patient needs, and will learn counseling techniques to help patients achieve and maintain their weight loss goals.

Supported by an educational grant from Novo Nordisk, Inc.

Managing Obesity and Comorbid Conditions: Welcome, Introductions and Opening Remarks

Chairperson: Robert H. Eckel, MD

Individualizing Treatment Strategies: Stratifying Cardiometabolic Risk in Obese Patients

Faculty: Jamy D. Ard, MD

How the Gut Talks to the Brain: Clinical Implications for Weight Loss

Faculty: George A. Bray, MD

Advances in Therapeutic Interventions for Weight Loss: What Is the Evidence and Where Are We Going?

Faculty: Michael D. Jensen, MD

Expert Strategies to Optimize the Management of the Obese Patient and Reduce Cardiometabolic Risk Interactive Panel Discussion, Case Presentations, and Audience Q&A

Moderator: Robert H. Eckel, MD

Discussants: Jamy D. Ard, MDGeorge A. Bray, MDMichael D. Jensen, MD